- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Albion Financial Group UT Trims AbbVie Inc. Stake
Institutional investor reduces holdings in pharmaceutical company
Apr. 7, 2026 at 7:04am
Got story updates? Submit your updates here. ›
An institutional investor's reduction in holdings of a major pharmaceutical stock reflects the complex financial landscape behind the healthcare industry.North Chicago TodayAlbion Financial Group UT, an institutional investor, has trimmed its holdings in AbbVie Inc. (NYSE:ABBV) by 47.9% in the fourth quarter, according to a recent 13F filing with the Securities and Exchange Commission (SEC). The firm now owns 23,971 shares of the company's stock, valued at $5,477,000 at the end of the reporting period.
Why it matters
This reduction in Albion Financial Group UT's AbbVie stake is noteworthy as it provides insight into the investment decisions of institutional investors and their views on the pharmaceutical company's performance and prospects. Tracking changes in institutional ownership can offer valuable clues about the market's sentiment towards a stock.
The details
According to the 13F filing, Albion Financial Group UT sold 22,007 shares of AbbVie during the fourth quarter, reducing its total holdings in the company by 47.9%. The firm now owns 23,971 shares of AbbVie's stock, which were valued at $5,477,000 at the end of the reporting period.
- The 13F filing covers the fourth quarter of the year.
The players
Albion Financial Group UT
An institutional investor that has reduced its holdings in AbbVie Inc.
AbbVie Inc.
A global, research-driven biopharmaceutical company that focuses on discovering, developing, and commercializing therapies for complex and often chronic medical conditions.
The takeaway
The reduction in Albion Financial Group UT's AbbVie stake suggests that the institutional investor may have concerns about the pharmaceutical company's performance or future prospects. This change in ownership could signal a broader shift in market sentiment towards AbbVie, which investors will want to monitor closely.
